|
Parsian, A; Suarez, B K; Isenberg, K et al. (1997) No evidence for a schizophrenia susceptibility gene in the vicinity of IL2RB on chromosome 22. Am J Med Genet 74:361-4
|
|
Doll, J A; Suarez, B K; Donis-Keller, H (1996) Association between prostate cancer in black Americans and an allele of the PADPRP pseudogene locus on chromosome 13. Am J Hum Genet 58:425-8
|
|
Smith, D S; Bullock, A D; Catalona, W J et al. (1996) Racial differences in a prostate cancer screening study. J Urol 156:1366-9
|
|
Smith, D S; Catalona, W J; Herschman, J D (1996) Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA 276:1309-15
|
|
Humphrey, P A; Keetch, D W; Smith, D S et al. (1996) Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 155:816-20
|
|
Catalona, W J; Smith, D S; Wolfert, R L et al. (1995) Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-20
|
|
Smith, D S; Catalona, W J (1995) Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45:70-4
|
|
Nadler, R B; Humphrey, P A; Smith, D S et al. (1995) Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154:407-13
|
|
Keetch, D W; Humphrey, P; Stahl, D et al. (1995) Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 154:347-51
|
|
Humphrey, P A; Zhu, X; Zarnegar, R et al. (1995) Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147:386-96
|
Showing the most recent 10 out of 19 publications
